IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045

Diabetes Research and Clinical Practice

Volumn 138, Issue , 2018, Pages 271-281

  Cho, N H ^a,c   Shaw, J E ^b   Karuranga, S ^a   Huang, Y ^a   da Rocha Fernandes, J D ^a   Ohlrogge, A W ^a   Malanda, B ^a  

^a International Diabetes Federation   (Belgium)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c Ajou University School of Medicine   (South Korea)

Author keywords

Diabetes prevalence; Epidemiology; Gestational diabetes; Health economics; Impaired glucose tolerance; Mortality

Indexed keywords

AGE DISTRIBUTION; ARTICLE; DIABETES MELLITUS; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; LOW INCOME COUNTRY; MIDDLE INCOME COUNTRY; MORTALITY; PREDICTION; PREGNANCY DIABETES MELLITUS; PREVALENCE; SYSTEMATIC REVIEW; ADOLESCENT; ADULT; AGED; ECONOMICS; FEMALE; FORECASTING; GEOGRAPHY; GLOBAL HEALTH; GLUCOSE INTOLERANCE; MALE; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATION; STATISTICS AND NUMERICAL DATA; TRENDS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DIABETES MELLITUS; FEMALE; FORECASTING; GEOGRAPHY; GLOBAL HEALTH; GLUCOSE INTOLERANCE; HEALTH EXPENDITURES; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS; PREVALENCE; YOUNG ADULT;

EID: 85043509509     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2018.02.023     Document Type: Article

References (40)

1. Baena-Díez, J.M., Peñafiel, J., Subirana, I., et al. Risk of cause-specific death in individuals with diabetes: a competing risks analysis. Diabetes Care 39:11 (2016), 1987–1995, 10.2337/dc16-0614.
2. World Health Organization, Global health risks: mortality and burden of disease attributable to selected major risks. 2009, Switzerland, Geneva Available at: .
3. Shaw, J.E., Sicree, R.A., Zimmet, P.Z., Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87:January (1) (2010), 4–14.
4. Whiting, D.R., Guariguata, L., Weil, C., Shaw, J., IDF Diabetes Atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94:December (3) (2011), 311–321.
5. Ogurtsova, K., da Rocha Fernandes, J.D., Huang, Y., Linnenkamp, U., Guariguata, L., Cho, N.H., et al. IDF Diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 128 (2017), 40–50, 10.1016/j.diabres.2017.03.024 Epub 2017 Mar 31.
6. Guariguata, L., Whiting, D.R., Hambleton, I., Beagley, J., Linnenkamp, U., Shaw, J.E., Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 103:2 (2014), 137–149, 10.1016/j.diabres.2013.11.002 Epub 2013 Dec 1.
7. Blas E, Kuru A, editors. Diabetes: equity and social determinants. In: Equity, social determinants and public health programmes. Geneva: World Health Organization; 2010.
8. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4*4 million participants. Lancet, 2016, 1980, 10.1016/S0140-6736(16)00618-8 published online April 7.
9. International Diabetes Federation, IDF Diabetes Atlas. 1st ed., 2000, International Diabetes Federation, Brussels, Belgium.
10. International Diabetes Federation, IDF Diabetes Atlas. 2nd ed., 2003, International Diabetes Federation, Brussels, Belgium.
11. International Diabetes Federation, IDF Diabetes Atlas. 3rd ed., 2006, International Diabetes Federation, Brussels, Belgium.
12. International Diabetes Federation, IDF Diabetes Atlas. 4th ed., 2009, International Diabetes Federation, Brussels, Belgium.
13. International Diabetes Federation, IDF Diabetes Atlas. 5th ed., 2011, International Diabetes Federation, Brussels, Belgium.
14. International Diabetes Federation, IDF Diabetes Atlas. 6th ed., 2013, International Diabetes Federation, Brussels, Belgium.
15. International Diabetes Federation, IDF Diabetes Atlas. 7th ed., 2015, International Diabetes Federation, Brussels, Belgium.
16. Saaty, T.L., Decision making with the analytic hierarchy process. Int J Serv Sci 1 (2008), 83–97, 10.1504/IJSSCI.2008.017590.
17. Ogurtsova K, Guariguata L, Whiting D, Unwin N, Weil C, da Rocha Fernandes J., et al. Sensitivity analysis of the global diabetes prevalence estimate in the IDF Diabetes Atlas (Poster). In: International diabetes epidemiology group. Vancouver; 2015.
18. World Bank Group. World bank country and lending groups. Data Help Desk; 2017.
19. Central Intelligence Agency, Country profiles, World factbook. 2015, Central Intelligence Agency, Fairfax, USA.
20. R Core Team, R: a language and environment for statistical computing. 2012, R Foundation for Statisticalv Computing, Vienna, Austria.
21. United Nations, Department of Economic and Social Affairs, Population Division. World urbanization prospects: the 2014 revision. New York, USA: United Nations Population Division; 2014.
22. Ogurtsova, K., Guariguata, L., Whiting, D., Unwin, N., Weil, C., Fernandes, J.D.R., et al. Incorporating uncertainty measurement in the International Diabetes Federation Diabetes Atlas methodology for estimating global and national prevalence of diabetes in adults (Poster). Arch Public Health, 73, 2015, 10.1186/2049-3258-73-S1-P31.
23. United Nations, Department of Economic and Social Affairs, Population Division. World population prospects: the 2015 revision. New York, USA: World Population Prospects; 2015.
24. Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJ, Lozano R, Inoue M. Age standardization of rates: a new WHO standard (GPE Discussion Paper Series: No. 31). Geneva, Switzerland: World Health Organization; 2001.
25. Linnenkamp, U., Guariguata, L., Beagley, J., Whiting, D.R., Cho, N.H., The IDF Diabetes Atlas methodology for estimating global prevalence of hyperglycaemia in pregnancy. Diabetes Res Clin Pract 103 (2014), 186–196, 10.1016/j.diabres.2013.11.004.
26. Ogurtsova, K., da Rocha Fernandes, J., Cavan, D., Makaroff LEIDF Atlas Group. Global estimates for undiagnosed diabetes for the 2015 IDF diabetes Atlas: a revision of the methodology. 2016, American Diabetes Association Scientific Sessions (Poster), New Orleans, USA.
27. da Rocha, Fernandes J., Ogurtsova, K., Linnenkamp, U., Guariguata, L., Seuring, T., Zhang, P., et al. IDF diabetes atlas estimates of 2014 global health expenditures on diabetes. Diabetes Res Clin Pract 117 (2016), 48–54, 10.1016/j.diabres.2016.04.016.
28. IDF Diabetes Atlas Group, Update of mortality attributable to diabetes for the IDF Diabetes Atlas: estimates for the year 2011. Diabetes Res Clin Pract 100 (2013), 277–279, 10.1016/j.diabres.2013.02.005.
29. Roglic, G., Unwin, N., Mortality attributable to diabetes: estimates for the year 2010. Diabetes Res Clin Pract 87 (2010), 15–19, 10.1016/j.diabres.2009.10.006.
30. Al-Rubeaan, K., et al. All-cause mortality and its risk factors among type 1 and type 2 diabetes mellitus in a country facing diabetes epidemic. Diabetes Res Clin Pract 118 (2016), 130–139.
31. Kang, Y.M., Kim, Y.-J., Park, J.-Y., Lee, W.J., Jung, C.H., Mortality and causes of death in a national sample of type 2 diabetic patients in Korea from 2002 to 2013. Cardiovasc Diabetol, 15, 2016.
32. Harding, J.L., et al. Mortality trends among people with type 1 and type 2 diabetes in Australia: 1997–2010. Diabetes Care 37 (2014), 2579–2586.
33. Pildava, S., Strēle, I., Briģis, G., The mortality of patients with diabetes mellitus in Latvia 2000–2012. Med Kaunas Lith 50 (2014), 130–136.
34. Bragg, F., et al. Association between diabetes and cause-specific mortality in rural and urban areas of China. JAMA 317 (2017), 280–289.
35. Alegre-Díaz, J., et al. Diabetes and cause-specific mortality in Mexico City. N Engl J Med 375 (2016), 1961–1971.
36. Kaul, P., Savu, A., Nerenberg, K.A., Donovan, L.E., Chik, C.L., Ryan, E.A., et al. Impact of gestational diabetes mellitus and high maternal weight on the development of diabetes, hypertension and cardiovascular disease: a population-level analysis. Diabet Med J Br Diabet Assoc 32 (2015), 164–173, 10.1111/dme.12635.
37. Rivera, L.A., Lebenbaum, M., Rosella, L.C., The influence of socioeconomic status on future risk for developing Type 2 diabetes in the Canadian population between 2011 and 2022: differential associations by sex. Int J Equity Health, 14, 2015, 101, 10.1186/s12939-015-0245-0.
38. Basu, S., Yoffe, P., Hills, N., Lustig, R.H., The relationship of sugar to population-level diabetes prevalence: an econometric analysis of repeated cross-sectional data. PLoS ONE, 8, 2013, e57873, 10.1371/journal.pone.0057873.
39. Siegel, K.R., Echouffo-Tcheugui, J.B., Ali, M.K., Mehta, N.K., Narayan, K.M., Chetty, V., Societal correlates of diabetes prevalence: an analysis across 94 countries. Diabetes Res Clin Pract 96 (2012), 76–83, 10.1016/j.diabres.2011.11.014.
40. Razavian, N., Blecker, S., Schmidt, A.M., Smith-McLallen, A., Nigam, S., Sontag, D., Population-level prediction of type 2 diabetes from claims data and analysis of risk factors. Big Data 3 (2015), 277–287, 10.1089/big.2015.0020.